222

KAINOS MEDICINE, INC.

No trades
See on Supercharts
Market capitalization
‪145.92 B‬KRW
‪−15.24 B‬KRW
‪267.31 M‬KRW
‪22.11 M‬
Beta (1Y)
1.24
Employees (FY)
19
Change (1Y)
−1 −5.00%
Revenue / Employee (1Y)
‪10.81 K‬KRW
Net income / Employee (1Y)
‪−615.82 K‬KRW

About KAINOS MEDICINE, INC.


CEO
Ki-Sub Lee
Headquarters
Seongnam-si
Founded
2007
ISIN
KR7284620002
FIGI
BBG00JHQYHB5
Kainos Medicine, Inc. engages in the research and development of pharmaceutical products. It develops degenerative brain disease treatment, anti-viral, and anti-cancer drugs. The company was founded on June 15, 2007 and is headquartered in Seongnam-si, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 284620 is 5,280 KRW — it has decreased by −0.77% in the past 24 hours. Watch KAINOS MEDICINE, INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange KAINOS MEDICINE, INC. stocks are traded under the ticker 284620.
284620 stock has risen by 8.90% compared to the previous week, the month change is a 16.82% rise, over the last year KAINOS MEDICINE, INC. has showed a 61.22% increase.
284620 reached its all-time high on Aug 5, 2020 with the price of 30,510 KRW, and its all-time low was 2,280 KRW and was reached on Apr 16, 2024. View more price dynamics on 284620 chart.
See other stocks reaching their highest and lowest prices.
284620 stock is 4.05% volatile and has beta coefficient of 1.24. Track KAINOS MEDICINE, INC. stock price on the chart and check out the list of the most volatile stocks — is KAINOS MEDICINE, INC. there?
Today KAINOS MEDICINE, INC. has the market capitalization of ‪144.03 B‬, it has increased by 8.62% over the last week.
Yes, you can track KAINOS MEDICINE, INC. financials in yearly and quarterly reports right on TradingView.
284620 net income for the last quarter is ‪−3.02 B‬ KRW, while the quarter before that showed ‪−2.53 B‬ KRW of net income which accounts for −19.51% change. Track more KAINOS MEDICINE, INC. financial stats to get the full picture.
No, 284620 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 5, 2024, the company has 19.00 employees. See our rating of the largest employees — is KAINOS MEDICINE, INC. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KAINOS MEDICINE, INC. EBITDA is ‪−12.80 B‬ KRW, and current EBITDA margin is ‪−5.81 K‬%. See more stats in KAINOS MEDICINE, INC. financial statements.
Like other stocks, 284620 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KAINOS MEDICINE, INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KAINOS MEDICINE, INC. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KAINOS MEDICINE, INC. stock shows the buy signal. See more of KAINOS MEDICINE, INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.